Dr. Irum Basheer is a researcher in cancer pharmacology and translational oncology, with a focus on the molecular mechanisms driving tumor progression and therapeutic resistance. Her work investigates signaling pathways, particularly MAPK-mediated mechanisms, and their role in modulating drug response in hepatocellular carcinoma and glioma models. Her research integrates molecular and cellular biology approaches to evaluate combination therapeutic strategies and identify pathway-based targets that may enhance treatment efficacy. She has experience in cancer cell models, pathway analysis, gene and protein expression studies, and functional assays assessing proliferation, apoptosis, and drug sensitivity. Her broader research objective is to contribute to the rational development of targeted and combinational therapies for high-burden malignancies.